Article

Have a look at the eight major steps taken by the government to provide a better healthcare system in India (2018). Narendra Modi healthcare schemes and targets.

You have read of your 8 free articles this month.

Subscribe to
Medgenera All-Access

Enjoy unlimited access to all contents, resources, exclusive market research reports, databases, surveys and many more features by subscribing to Medgenera All-Access.

Access articles & resources worth up to US $4, 000 per month.

Register with your email to read the full article.

This article is FREE for you! Unlock the unlimited access by subscribing to Medgenera All-Access.

More in NEWLY PUBLISHED


NEWLY PUBLISHED

21 Leading Indian Cancer Startups

India is expected to have over 17.3 lakh new cases of cancer of which more than 8.8 lakh are likely ...

NEWLY PUBLISHED

40 World’s Top Selling Drugs by 2022

Drugs for a plethora of diseases like cancers, arthritis, HIV, diabetes, rare diseases are anticipated to make it big in ...

Artificial Intelligence

UPDATE: Indian Artificial Intelligence Startup Bags $19 Million for Healthcare Solutions

Bangalore-based Artificial Intelligence (AI) startup, SigTupleĀ has raisedĀ $19 million (about INR 130 crore) in series B funding round led by Accel Partners and IDG Ventures. SigTuple funding.

DRUG TRIAL

FDA Approves First Therapy ‘Gilenya’ for Children with Multiple Sclerosis

Gilenya is the first FDA-approved drug for the treatment of multiple sclerosis (MS) in pediatric patients. Earlier it was approved in 2010 to treat adult patients with relapsing MS.

Most Popular


GROW

7 New Ideas to Start a Healthcare Business in India (2018)

Seven new #healthcare #business ideas in India in 2018. Which one would you prefer to pursue?

NEWLY PUBLISHED

Pharma Patents: Can India Reward Incremental Innovation?

Chandramouli Natarajan is an Associate Scientist, Ricon pharma LLC, Denville, USA. He has presented his opinion and views on the Pharmaceutical patents issues in India. This article is available for free to read and share.

Leave a reply